# Eli Lilly & Co. agrees to buy Kelonia Therapeutics for as much as $7 billion.

*biotech · news · 2026-04-20 · The Boston Globe*

## Key points

- Eli Lilly is acquiring Kelonia Therapeutics for up to $7 billion.
- Kelonia's lead drug uses in vivo CAR-T technology for multiple myeloma patients.
- The novel therapy does not require immune cell removal or pre-infusion chemotherapy.
- Kelonia is enrolling patients in an early-stage trial for this new treatment.

**Companies:** Eli Lilly & Co., Kelonia Therapeutics
**Countries:** United States

[Read the full story on The Boston Globe](https://www.bostonglobe.com/2026/04/20/business/eli-lilly-cancer-biotech-kelonia/)

---

Canonical: https://newsio.io/n/c97e89cc-86cb-48e8-8eb7-98b0829ecdca/eli-lilly-co-agrees-to-buy-kelonia-therapeutics-for-as-much-as-7-billion-kelonia
Summarized by Newsio from The Boston Globe. https://newsio.io/how-it-works